|
시장보고서
상품코드
2077582
자궁경부 이형성 시장 : 진단 유형별, 최종 사용자별, 지역별Cervical Dysplasia Market, By Diagnosis Type, By End User, By Geography |
||||||
자궁경부 이형성 시장은 2026년에 8억 8,550만 달러 규모가 될 것으로 추정되고 있어 2033년에 14억 8,830만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 7.7%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 8억 8,550만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년까지 예측 기간 CAGR : | 7.70% | 2033년 시장 규모 예측 : | 14억 8,830만 달러 |
자궁경부 이형성이란, 자궁으로 들어가는 입구인 자궁경부의 내막을 구성하는 세포에 발생하는 전암성 병변을 말합니다. 이러한 변화는 골반 내진 시 자궁경부에서 채취한 세포 검체를 현미경으로 분석하여 확인됩니다. '편평상피내 병변(SIL)'이란 자궁경부에서 채취한 세포 도말 검체에서 관찰되는 자궁경부 이형성을 가리키는 병리학적 용어입니다. 자궁경부 이형성은 인유두종 바이러스(HPV) 감염에 의해 발생합니다. HPV는 성적 접촉을 통해 감염되는 매우 흔한 감염병입니다. HPV 신규 감염의 대부분은 15세에서 25세 사이의 젊은 여성에게서 발생합니다. HPV 감염의 대부분은 증상을 보이지 않으며, 자연적으로 치유됩니다.
시장 역학
주요 시장 진출 기업들의 유기적 성장 전략 확대가 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2021년 3월 1일, 감염병, 암, HPV 관련 질환의 치료 및 예방을 목적으로 정밀하게 설계된 데옥시리보핵산(DNA) 의약품 시장 출시를 주력하고 있는 생명공학 기업 INOVIO는 REVEAL 1 임상시험에서 평가 가능한 모든 피험자에서 주요 평가 지표와 부차적 평가 지표를 달성했다고 발표했습니다. 이 임상시험은 해당 회사의 독자적인 CELLECTRA 5PSP 장치를 사용하여, HPV-16/18과 관련된 자궁경부 고도 편평상피내 병변(HSIL) 치료제로서의 VGX-3100의 안전성, 내약성, 유효성을 평가하는 현재 진행 중인 두 건의 주요 무작위 배정 이중 맹검 다기관 공동 위약 대조 3상 임상시험 중 하나입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 자궁경부 이형성 시장 : 진단 유형별, 2021-2033년
제5장 자궁경부 이형성 시장 : 최종 사용자별, 2021-2033년
제6장 자궁경부 이형성 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
JHS 26.07.13Cervical Dysplasia Market is estimated to be valued at USD 885.5 Mn in 2026 and is expected to reach USD 1,488.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 885.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.70% | 2033 Value Projection: | USD 1,488.3 Mn |
Cervical dysplasia is precancerous changes of the cells that make up the lining of the cervix, the opening to the womb (uterus). These changes are detected by microscopic analysis of cell samples which are taken from the cervix during a pelvic exam. Squamous intraepithelial lesion is the pathology term that is used to refer to cervical dysplasia which is observed in smears of cells taken from the cervix. Cervical dysplasia is caused by infection with the human papillomavirus (HPV). HPV is a very common infection that is transmitted through sexual contact. Most new HPV infections occur in young (ages 15-25) women. Most HPV infections do not produce any symptoms and resolve spontaneously.
Market Dynamics:
Increasing organic strategies by the key market players is expected to drive the market growth over the forecast period. For instance, on March 1, 2021, INOVIO, a biotechnology company focused on bringing to market precisely designed deoxyribonucleic acid (DNA)medicines to treat and protect people from infectious diseases, cancer and HPV-associated diseases, announced that it met primary and secondary endpoints among all evaluable subjects for the REVEAL 1 trial. This trial is one of two ongoing pivotal, randomized, double-blind, multi-center, placebo-controlled, Phase 3 trials evaluating the safety, tolerability, and efficacy of VGX-3100 to treat HPV-16/18-associated cervical high-grade squamous intraepithelial lesions (HSIL) using the company's proprietary CELLECTRA 5PSP device.
Cervical Dysplasia Market Detailed Segmentation:
- By Diagnosis Type (Revenue, USD Mn, 2021 - 2033)
- Diagnosis Test
- HPV Test
- Pap Smear Test
- Biopsy Test
- Diagnostic Device
- Colposcope
- By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Diagnostic Centers
- Ambulatory Surgery Centers
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in Cervical Dysplasia Market:
- Roche
- Qiagen
- Abbott Laboratories
- BD
- Hologic
- Seegene
- Arbor Vita
- Femasys
- Cooper Surgical
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Diagnosis Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing government initiatives
- Growing prevalence of cervical dysplasia globally
- Restraints
- Lack of awareness in developing nations
- Opportunities
- Increasing government funding
- Drivers
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions and Collaborations
4. Cervical Dysplasia Market, By Diagnosis Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Diagnosis Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- HPV Test
- Pap Smear Test
- Biopsy Test
- Diagnostic Device
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Colposcope
5. Cervical Dysplasia Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Cervical Dysplasia Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2023and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- China
- Japan
- India
- Australia
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Mn)
- South Africa
- North Africa
- Central Africa
7. Competitive Landscape
- Company Profile
- Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hologic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Seegene
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Arbor Vita
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Femasys
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cooper Surgical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
- Roche
8. Section
- References
- Research Methodology
- About us
